GGrantIndex
← Leaderboards

Jeffrey H Boatright

Veterans Health Administration

$9,074,494
Attributed
$13,390,419
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,390,419 · 9
VA$0 · 3

By mechanism

R01$10,539,806 · 5
P30$2,420,238 · 3
R21$430,375 · 1
I01$0 · 2
I21$0 · 1

Top collaborators

Most similar at Veterans Health Administration

Same institution · by research overlap

Others in their field

Top investigators on “Retina

Research focus

RetinaVisionResponseSmall MoleculeRetinal DegenerationExperimental StudyDesignLightBlindnessIn VivoMorphologyCellsMolecularClinicFundingAffectPreventSignal TransductionStructureMouse ModelInnovationCessation Of LifePhotoreceptorsProteins

Grant awards (49)

P30-Core Grant for Vision Research Core B$257,594
P30 · FY2025 · EY · contact PI
The Active AMD Study to Improve Function in Veterans with Age Related Macular Degeneration$0
I01 · FY2025 · VA
P30-Core Grant for Vision Research Core B$257,594
P30 · FY2024 · EY · contact PI
Atypical opsins and the OIR model of retinopathy of prematurity$195,625
R21 · FY2024 · EY
The Active AMD Study to Improve Function in Veterans with Age Related Macular Degeneration$0
I01 · FY2024 · VA
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2024 · VA · contact PI
P30-Core Grant for Vision Research Core B$257,594
P30 · FY2023 · EY · contact PI
Atypical opsins and the OIR model of retinopathy of prematurity$234,750
R21 · FY2023 · EY
The RPE and Recovery of the Blood Retina Barrier$471,427
R01 · FY2022 · EY
P30-Core Grant for Vision Research Core B$257,594
P30 · FY2022 · EY · contact PI
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2022 · VA · contact PI
Exercise-induced Retinal Neuroprotection$483,102
R01 · FY2021 · EY · contact PI
The RPE and Recovery of the Blood Retina Barrier$471,426
R01 · FY2021 · EY
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)$423,697
R01 · FY2021 · EY
P30-Core Grant for Vision Research Core B$257,594
P30 · FY2021 · EY · contact PI
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2021 · VA · contact PI
Exercise-induced Retinal Neuroprotection$498,044
R01 · FY2020 · EY · contact PI
The RPE and Recovery of the Blood Retina Barrier$486,006
R01 · FY2020 · EY
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)$436,802
R01 · FY2020 · EY
P30-Core Grant for Vision Research Core B$225,537
P30 · FY2020 · EY · contact PI
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2020 · VA · contact PI
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2020 · VA · contact PI
Exercise-induced Retinal Neuroprotection$498,044
R01 · FY2019 · EY · contact PI
The RPE and Recovery of the Blood Retina Barrier$486,006
R01 · FY2019 · EY
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)$436,802
R01 · FY2019 · EY
P30-Core Grant for Vision Research Core B$230,640
P30 · FY2019 · EY · contact PI
A TrkB Activator for Treatment of Glaucoma$0
I01 · FY2019 · VA · contact PI
Exercise-induced Retinal Neuroprotection$521,653
R01 · FY2018 · EY · contact PI
The RPE and Recovery of the Blood Retina Barrier$515,444
R01 · FY2018 · EY
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)$436,802
R01 · FY2018 · EY
P30-Core Grant for Vision Research Core B$238,738
P30 · FY2018 · EY · contact PI
P30-Core Grant for Vision Research Core B$242,964
P30 · FY2017 · EY · contact PI
Bridging animal and human models of exercise-induced visual rehabilitation$0
I21 · FY2017 · VA · contact PI
P30-Core Grant for Vision Research Core B$194,389
P30 · FY2016 · EY · contact PI
Bridging animal and human models of exercise-induced visual rehabilitation$0
I21 · FY2016 · VA · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$379,750
R01 · FY2015 · EY · contact PI
Bridging animal and human models of exercise-induced visual rehabilitation$0
I21 · FY2015 · VA · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$379,750
R01 · FY2014 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$368,125
R01 · FY2013 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$387,500
R01 · FY2012 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$334,276
R01 · FY2012 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$387,500
R01 · FY2011 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$363,992
R01 · FY2008 · EY · contact PI
Oligonucleotide Repair of a Retinal Degeneration Model$371,420
R01 · FY2007 · EY · contact PI
Oligonucleotide Repair of a Retinal Degenerarion Model$373,511
R01 · FY2006 · EY · contact PI
Oligonucleotide Repair of a Retinal Degenerarion Model$382,500
R01 · FY2005 · EY
Oligonucleotide Repair of a Retinal Degeneration Model$366,600
R01 · FY2004 · EY
PERMISSIVE RETINAL GENE EXPRESSION VIA HYPOMETHYLATION$141,879
R01 · FY2001 · EY
PERMISSIVE RETINAL GENE EXPRESSION VIA HYPOMETHYLATION$137,748
R01 · FY2000 · EY